Items tagged with Advocacy
WHO: Latest information about the UN High-Level Meeting on TB and advocacy materials (post)
The World Health Organization (WHO) provided the latest logistical information regarding the upcoming UN High-Level Meeting on TB to be held on 22 September 2023 in New York City. It can be accessed here together with various advocacy materials.
Bill & Melinda Gates Foundation doubles its contribution to Unitaid to US$100 million over 5 years (post)
21 September 2023: The Bill & Melinda Gates Foundation announced a long-term commitment of $100 million to Unitaid to bring faster access to health products in low- and middle-income countries. This funding doubles the foundation’s previous commitment and will support Unitaid’s work to accelerate the introduction and delivery of new lifesaving solutions at equitable scale, including those for maternal and newborn health.
UNGA High-Level Week brought numerous announcements and commitments for TB response (post)
The Stop TB Partnership ensured that high-level TB side events were organized daily with support from partners and key stakeholders during the 78th session of the United Nations General Assembly (UNGA) High-Level Week from 18-22 September 2023.
Patients’ rights groups accuse Union health ministry of denying shortages of key medicines for drug-resistant TB (post)
Patients’ rights groups have accused the Union health ministry of denying shortages of key medicines for drug-resistant tuberculosis (TB) even though they say the ministry’s own figures of drug inventories indicate why patients are facing shortages.
WGNV newsletter: Latest updates on TB vaccines (post)
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) released a newsletter with the latest updates related to the TB vaccine research and development.
TB patients across India struggle with acute drug shortages, government denies but WHO worried (post)
New Delhi, 01/Oct/2023: In an unusual repetition of sorts, the Union health ministry issued a press release on Sunday, October 1, denying any shortages of essential medicines for drug-resistant TB patients. It was only on September 26 that the ministry issued an almost similar statement.
UCT prof calls for increased investment in TB vaccine research (post)
During a panel discussion of the United Nations High-level Meeting on TB held in New York City on 22 September 2023, Professor Mark Hatherill, the director at the South African Tuberculosis Vaccine Initiative (SATVI) based at the University of Cape Town (UCT), called for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
WHO #EndTB webinar: Virtual launch of the Guidance on engagement of communities and civil society to end TB (post)
The World Health Organization (WHO) will host a webinar on 13 October 2023 to present the new Guidance on engagement of communities and civil society to end TB which aims to strengthen collaboration and leverage capacities of communities and civil society in line with the End TB Strategy.
WHO call for expression of interest: Civil society representatives in the TB vaccine accelerator council (post)
The World Health Organization (WHO) Global TB Program is providing secretariat support to the TB vaccine accelerator council, which was recently established to facilitate the development, licensing and use of safe TB vaccines that are impactful in halting the TB epidemic. Civil society representatives with relevant expertise and experience are invited to respond to a call for expression of interest to be engaged in the leadership group of the Council. The deadline to apply is 18 October 2023.
World Diabetes Day 2023: Equitable access to care for people with TB and diabetes (post)
13 November 2023 | Geneva -- In advance of the World Diabetes Day, which is marked on November 14, WHO is highlighting the need for equitable access to essential care for people affected by diabetes and tuberculosis (TB). Equitable access to care is essential to ending TB, as highlighted in WHO’s End TB Strategy and reinforced in the political declarations of the United Nations high-level meetings on the fight against TB in 2018 and 2023. According to the 2023 WHO Global TB Report, diabetes is one of the key determinants of TB, with just under 400,000 TB episodes attributable to diabetes worldwide. People with diabetes are at higher risk of developing TB and are more likely to experience poor TB treatment outcomes, including death. This emphasises the need for ensuring access to comprehensive care for people affected by both diabetes and TB.
Page 57 of 127 · Total posts: 0
←First 56 57 58 Last→